Dietary modification is considered a cornerstone in the management of diabetes superimposed upon which are pharmacological therapies as required. The value of hypocaloric diets in reducing and eliminating glycosuria was extolled in the pre-insulin era. A common feature of the nutrient balance of these diets was restriction in the availability of carbohydrate. Herein we review the use of diet as therapy in the past and discuss the rationale for hypocaloric dietary management of type 2 diabetes in the 21st century, drawing comparisons with bariatric surgery and considering why weight loss is particularly difficult for overweight and obese individuals with type 2 diabetes.
HenryRRWiest-KentTAScheafferL. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes1986;35:155–64.
2.
WingRRKoeskeREpsteinLH. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med. 1987;147:1749-53.
3.
KelleyDEWingRBuonocoreC. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab1993;77:1287-93.
4.
WingRRBlairEHBononiP. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care1994;17:30-36.
5.
LimELHollingsworthKGAribisalaBS. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia2011;54:2506-14.
6.
WilliamsKVMullenMLKelleyDEWingRR. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care1998;21:2-8.
7.
FujokaK. Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes Obes Metab2010;12:186-94
8.
KodamSSaitoKTanakaS. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: A meta-analysis. Diabetes Care2009;32:959-65.
9.
HeilbronnLKNoakesMCliftonPM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care1999;22:889-95.
10.
HensrudDD. Dietary treatment and long-term weight loss and maintenance in type 2 diabetes. Obesity Research2001;9:s348–53.
11.
American Diabetes Association position statement. Nutrition recommendations and interventions for diabetes. Diabetes Care2008;31:Suppl 1S61-78.
12.
WingRRMarcusMDEpsteinLHSalataR. Type II diabetic subjects lose less weight than their overweight non-diabetic spouses. Diabetes Care1987;10:563–66.
13.
AstrupAGotzschePCvandeWerkenK. Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutrit1999;69:1117-22.
14.
HeymsfieldSBHarpJBReitmanML.Why do obese patients not lose more weight when treated with low-calorie diets? A mechanistic perspective. Am J Clin Nutr2007;85:346–54.
15.
FlattPRDayCBaileyCJ. Bariatric surgery to treat diabesity. Br J Diabetes Vasc Dis2009;9:103-7.
16.
SpeckMChoYMAsadiA. Duodenal-jejunal bypass protects GK rats from beta-cell loss and aggravation of hyperglycemia and increased enteroendocrine cells coexpressing GIP and GLP-1. Am J Physiol Endocrinol Metab2011;300:E923-32.
17.
de JongCVerdamFJRensenSS. Endobarrier™ duodenal-jejunal bypass liner rapidly improves diabetes parameters paralleled by increased postprandial GLP-1 and PYY levels in obese type 2 diabetic patients. Diabetologia2011;54:Suppl1, Abstr 186.
18.
FlattPR. Gastric inhibitory polypeptide revisited: a new therapeutic target for obesity-diabetes. Diabetic Med2008;25:759-64.
Dall’OlioG. Appunti di storia Il diabete nell’Ottocento, La cura del Cantani. G It Diabetol Metab2007;27:146-53.
21.
MacFarlaneIABlissMJacksonJGLWilliamsG. The history of diabetes mellitus. In PickupJCWilliamsG (eds) in Textbook of diabetes, volume 1, 2nd edn.Blackwell Science, Oxford, UK. 2009 p1.1-1.21.
22.
Tattersall R. Diabetes. The biography. Oxford University Press, Oxford, UK. 2009.
23.
RolloJCruikshankW. An account of two cases of the diabetes mellitus. Vol I and Vol II. T. Gillet for C. Dilly, London, UK, 1797.
24.
NeildGH. William Cruickshank (FRS-1802): clinical chemist. Nephrol Dial Transplant1996;11:1885-9.
25.
WoodyattRT. Disorders of metabolism. Round table conference on diabetes mellitus. Dietary trends. Bull N.Y. Acad Med1934;10:335-46
26.
The ORIGIN Trial Investigators. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J2008;155:26-32.
27.
BennettP. Obesity, diabetes and VLCDs. Br J Diabetes Vasc Dis2004;4:328-30.
28.
BaldwinEJ. Fad diets in diabetes. Br J Diabetes Vasc Dis2004;4:333-7.
